Sartorius Aid Development of 1st Vaccine Candidate against SAR-CoV-2 to Enter Clinical Trials

CanSinoBIO and the Institute of Bioengineering saved time during development by usingSartorius BIOSTATSTR single-use bioreactor system for the upstream preparation of the recombinant vaccine

from rapidmicrobiology https://ift.tt/3dEVt0V

No comments:

Post a Comment